# RAPIBLYK

NDC: 87073-110
Generic name: landiolol
Labeler / Manufacturer: AOP Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250519

FDA application: NDA217202

## Active ingredients

- LANDIOLOL HYDROCHLORIDE: 280 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87073-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87073-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=411b0949-3a5e-2a4b-e063-6394a90abcbf